Keyphrases
Helicobacter Pylori (H. pylori)
86%
Oxidative Stress
77%
Total Antioxidant Capacity
68%
DNA Damage
67%
Oxidative Stress Markers
66%
Serum Leptin
64%
Oxidative Status
64%
Leptin Levels
53%
Hepatitis C Virus Infection
53%
Paraoxonase-1 Activity
53%
Nonalcoholic Steatohepatitis
53%
Helicobacter Pylori Infection
48%
Hemodialysis
45%
Ulcerative Colitis
44%
Total Peroxides
37%
Cirrhotic Patients
37%
Total Oxidant Status
36%
Case-controlled Study
35%
Hemodialysis Patients
35%
Hepatitis C
35%
Arylesterase Activity
35%
Lymphocyte DNA Damage
35%
Polyps
35%
Hepatitis B Virus Infection
35%
Turkey
35%
Pathological Findings
33%
Antioxidant Response
30%
Hepatitis B Surface Antigen (HBsAg)
30%
Risk Factors
30%
Healthy Controls
27%
Child-Pugh Score
26%
Alkaline Comet Assay
25%
Pregnant Women
24%
Serum Prolidase Activity
23%
Helicobacter Pylori Eradication
22%
Serum Paraoxonase
22%
Chronic Hepatitis
22%
Serum Arylesterase
22%
Cirrhosis
22%
Clinical Forms
22%
End-stage Renal Disease
21%
Fibrosis
20%
DNA Damage Stress
20%
DNA Oxidative Stress
20%
Gastric mucosal
20%
Endoscopy
20%
Prolidase Activity
20%
Liver Disease
19%
Paraoxonase 1 (PON1)
19%
Seropositivity
19%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Helicobacter Pylori
70%
Hemodialysis
61%
Hepatitis C
53%
Ulcerative Colitis
48%
Proline Dipeptidase
35%
Nonalcoholic Fatty Liver
35%
Leptin
35%
Aryldialkylphosphatase 1
35%
Comet Assay
33%
Helicobacter Infection
30%
Antioxidant Capacity
26%
Fibrosis
24%
Oxidizing Agent
23%
End Stage Renal Disease
20%
Disease
20%
Prevalence
18%
Hepatitis B
17%
Hepatitis B Virus
17%
Polyp
17%
Pepsinogen
17%
Atrophic Gastritis
17%
Colon Polyp
17%
Ranitidine Bismuth Citrate
17%
Chronic Hepatitis C
17%
Digestive System Cancer
17%
Delta Agent Hepatitis
17%
Peginterferon Alpha2b
17%
Prospective Study
17%
Insulin Resistance
17%
Peroxidase
17%
Gallstone
17%
Dysentery
17%
Hepatitis B Antigen
17%
Glutathione
17%
Malonaldehyde
17%
Glutathione Peroxidase
17%
Inflammatory Bowel Disease
17%
Arylesterase
17%
Aryldialkylphosphatase
17%
Inflammation
15%
Pepsinogen I
15%
Liver Cirrhosis
14%
Antioxidant
13%
Fibrinogen
13%
Plasminogen
13%
Lansoprazole
10%
Non Insulin Dependent Diabetes Mellitus
10%
Disease Activity
10%
Abdominal Cancer
10%
Medicine and Dentistry
Polyp
35%
Leptin
35%
DNA Damage
35%
Hepatitis B Virus
28%
Polysplenia
26%
Child-Pugh Score
26%
Oxidative Stress
24%
Prevalence
24%
Congenital Malformation
23%
Patient with Ulcerative Colitis
23%
Diagnosis
22%
Diseases
20%
Endoscopy
19%
Antioxidant
19%
Stomach Mucosa
19%
Factor V Leiden
19%
Hepatitis B
17%
Nonalcoholic Fatty Liver
17%
Polycythemia vera
17%
Budd-Chiari Syndrome
17%
Gallstone
17%
Cystadenoma
17%
Spleen Scintiscanning
17%
Dysentery
17%
Laryngitis
17%
Peutz Jeghers Syndrome
17%
Jejunal Intussusception
17%
Hypochromic Anemia
17%
Chronic Hepatitis C
17%
Abdominal Tuberculosis
17%
Defecation Habit
17%
Colon Polyp
17%
Human Immunodeficiency Virus
17%
Heterotopic
17%
Esophagus
17%
Lamivudine
17%
Mitomycin
17%
Laryngopharyngeal Reflux
17%
Portal Vein Thrombosis
17%
Portal Hypertension
17%
Fibrinogen
17%
Gastrointestinal Cancer
17%
Chronic Myelogenous Leukemia
17%
Lymphocyte
17%
Gastrointestinal System
17%
Inflammatory Bowel Disease
17%
Plasminogen
17%
Wound Healing
17%
Pylorus
17%
Helicobacter Pylori
17%
